NEUTROPHIL GELATINASE–ASSOCIATED LIPOCALIN (NGAL) AS AN EARLY BIOMARKER OF ACUTE KIDNEY INJURY IN HEPATIC PATIENTS

STUDY OF URINARY NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (NGAL) IN PATIENTS WITH LIVER CIRRHOSIS AND ITS RELATION TO HEPATORENAL SYNDROME

The Use of Neutrophil Gelatinase Associated Lipocalin (NGAL) As A Novel Marker in Early Diagnosis of Hepatorenal Syndrome in Advanced Cirrhotic Patients

Neutrophil gelatinase-associated lipocalin (NGAL) role in diagnosis of complications of liver cirrhosis

Urinary Neutrophil Gelatinase-Associated Lipocalin as Predictor for Development of Hepatorenal Syndrome in Patients with Hepatic Cirrhosis

URINARY NEUOTROPHIL GELATINASE ASSOCIATED LIPOCALIN AS A DIAGNOSTIC AND A PROGNOSTIC MARKER FOR RENAL INSULT IN CIRRHOTIC PATIENTS WITH SPONTANEOUS BACTERIAL PERITONITIS

Neutrophil gelatinase associated lipocalin: a new marker for early diagnosis of acute kidney injury in ICU

Impact of NGAL (Neutrophil Gelatinase Associated lipocalin) on Outcome of Hepato-renal Syndrome

Plasma and Urine Neutrophil Gelatinase-Associated Lipocalin (NGAL) as Early Predictor of Acute Kidney Injury in Septic Patients

Prognostic Value of Ascitic Neutrophil Gelatinase-Associated Lipocalin in Decompensated Liver Cirrhosis with Spontaneous Bacterial Peritonitis Patients